The Mononuclear Phagocyte System in Homeostasis and Disease: A Role for Heme Oxygenase-1
被引:66
作者:
Hull, Travis D.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Alabama Birmingham, Div Nephrol, Dept Med, Birmingham, AL 35226 USA
Univ Alabama Birmingham, Div Cardiothorac Surg, Dept Surg, Birmingham, AL 35226 USAUniv Alabama Birmingham, Div Nephrol, Dept Med, Birmingham, AL 35226 USA
Hull, Travis D.
[1
,2
]
论文数: 引用数:
h-index:
机构:
Agarwal, Anupam
[1
,3
]
George, James F.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Alabama Birmingham, Div Cardiothorac Surg, Dept Surg, Birmingham, AL 35226 USAUniv Alabama Birmingham, Div Nephrol, Dept Med, Birmingham, AL 35226 USA
George, James F.
[2
]
机构:
[1] Univ Alabama Birmingham, Div Nephrol, Dept Med, Birmingham, AL 35226 USA
[2] Univ Alabama Birmingham, Div Cardiothorac Surg, Dept Surg, Birmingham, AL 35226 USA
[3] Birmingham Vet Adm Med Ctr, Birmingham, AL USA
Significance: Heme oxygenase-1 (HO-1) is a potential therapeutic target in many diseases, especially those mediated by oxidative stress and inflammation. HO-1 expression appears to regulate the homeostatic activity and distribution of mononuclear phagocytes (MP) in lymphoid tissue under physiological conditions. It also regulates the ability of MP to modulate the inflammatory response to tissue injury. Recent Advances: The induction of HO-1 within MPparticularly macrophages and dendritic cellsmodulates the effector functions that they acquire after activation. These effector functions include cytokine production, surface receptor expression, maturation state, and polarization toward a pro- or anti-inflammatory phenotype. The importance of HO-1 in MP is emphasized by their expression of specific receptors that primarily function to ingest heme-containing substrate and deliver it to HO-1. Critical Issues: MP are the first immunological responders to tissue damage. They critically affect the outcome of injury to many organ systems, yet few therapies are currently available to specifically target MP during disease pathogenesis. Elucidation of the role of HO-1 expression in MP may help to direct broadly applicable therapies to clinical use that are based on the immunomodulatory capabilities of HO-1. Future Directions: Unraveling the complexities of HO-1 expression specifically within MP will more completely define how HO-1 provides cytoprotection in vivo. The use of models in which HO-1 expression is specifically modulated in bone marrow-derived cells will allow for a more complete characterization of its immunoregulatory properties. Antioxid. Redox Signal. 20, 1770-1788.
机构:
Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USAYale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA
Ackerman, AL
;
Cresswell, P
论文数: 0引用数: 0
h-index: 0
机构:
Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USAYale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA
机构:
Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USAYale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA
Ackerman, AL
;
Cresswell, P
论文数: 0引用数: 0
h-index: 0
机构:
Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USAYale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA